See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Products Videos on Diabetes Health TV

SideKick

Debbie Childers

SideKick

Bayer Demonstration Of Contour And Breeze Meters

P.J. Sheridan

Bayer Demonstration Of Contour And Breeze Meters

Stylish and Fashionable Testing Cases

Kyrra Richards

Stylish and Fashionable Testing Cases

Diabetes Health Reference Charts
Products Archives

Diabetes Products

Page 3
Tandem Diabetes Care Recalls Some t:slim Insulin Pump Cartridges

San Diego-based Tandem Diabetes Care®, Inc. announced Friday that it is voluntarily recalling specific lots of insulin cartridges that are used with the t:slim® Insulin Pump. The affected cartridges may be at risk for leaking.

Comments 0 comments - Jan 11, 2014 - * * * * *

New Type 2 Drugs Change Treatment Decisions

Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of that population in 1997 to 53 percent in 2012. But that increase has since plateaued due to the introduction of additional drugs that target insulin secretion and glucose regulation.

Comments 0 comments - Jan 4, 2014 - * * * * *

Nipro Diagnostics Recalls Certain TRUEbalance and TRUEtrack Meters

Nipro Diagnostics, Inc. today announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalanceTM and TRUEtrack® Blood Glucose Meters distributed both in and outside the United States.

Comments 0 comments - Jan 3, 2014 - * * * * *

Takeda Ceases Development of Type 2 Drug

Japanese drug maker Takeda, Asia's largest pharmaceutical company, and a major player in the global diabetes medication market, has ceased development of its type 2 drug, TAK-875 (fasiglifam).

Comments 0 comments - Dec 30, 2013 - * * * * *

Global CGM Market Will Reach $568.5 Million by 2020 Global CGM Market Will Reach $568.5 Million by 2020

PRNewswire--According to a new market research report, the global continuous glucose monitoring market is projected to reach $568.5 million by 2020--up significantly from the 2012 figure of $194.8 million due to a projected compound annual growth rate of 14.8 percent.

Comments 0 comments - Dec 28, 2013 - * * * * *

NeuroMetrix Launches www.SENSUSRx.com

Waltham, Mass.-based NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, has announced the launch of a consumer website, www.SENSUSRx.com.

Comments 0 comments - Dec 10, 2013 - * * * * *

Giving Thanks for Smart People at the Edges

One of my job as a member of the Diabetes Health staff is to manage the comments section on our website. Sometimes the comments get heated, and when they do certain patterns emerge.

Comments 0 comments - Nov 28, 2013 - * * * * *

Me, on a Continuous Glucose Monitor

Words. Images. Facts. Figures. Data. Times and dates. Over and over and over again. The defining characteristic of life in 2013 is this constant swirl of information. It surrounds us and envelops us. Many people seek a way out, a way to live without this constant barrage of email and Facebook updates, and tweets, and texts.

Comments 0 comments - Nov 22, 2013 - * * * * *

Big Changes Looming in Sharps Disposal Regs

As the chief executive officer of a company that manufactures insulin syringes and pen needles for the U.S. and Canadian markets, I have been monitoring the regulations and trends pertaining to their proper disposal. It's safe to assume that there may be significant changes in the United States related to the disposal method of used sharps devices-and it's likely that pharmacists will be affected by these future changes.

Comments 0 comments - Nov 19, 2013 - * * * * *

Promising New Type 2 Drug on Horizon

A new drug being developed by Eli Lilly Co. that duplicates the effects of a hormone may soon be added to the growing arsenal of pharmaceutical weapons available to treat type 2 diabetes.

Comments 0 comments - Nov 16, 2013 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.